ES2076437T3 - Analogos de pig y su uso. - Google Patents

Analogos de pig y su uso.

Info

Publication number
ES2076437T3
ES2076437T3 ES91116704T ES91116704T ES2076437T3 ES 2076437 T3 ES2076437 T3 ES 2076437T3 ES 91116704 T ES91116704 T ES 91116704T ES 91116704 T ES91116704 T ES 91116704T ES 2076437 T3 ES2076437 T3 ES 2076437T3
Authority
ES
Spain
Prior art keywords
lys
asn
homoserine
gip
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91116704T
Other languages
English (en)
Inventor
Masayasu Kurono
Takahiko Mitani
Haruo Takahashi
Ryoichi Unno
Tomoo Suzuki
Yuji Hayashi
Yohei Kobayashi
Yoko Ishii
Kiichi Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of ES2076437T3 publication Critical patent/ES2076437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRESENTAN ANALOGOS DEL PEPTIDO INHIBIDOR GASTRICO (GIP) Y LOS USOS DE LOS MISMOS. LOS ANALOGOS DEL GIP CODIFICAN UNA SECUENCIA DE ACIDO AMINO PRESENTADA POR LA SIGUIENTE FORMULA: EN LA X ES UN RESIDUO DE ACIDO AMINO DIFERENTE A MET, E Y ES A) HOMOSERINA (CON INCLUSION DE LA HEMOSERINA-LACTONA Y QUE SE INDICA POR UN SIMBOLO "HSE", B) AMIDO DE HOMOSERINA (HHSENH SUB 2), C) GLI-LIS-LIS-ASN-ASP-TRP-LIS-HIS-ASN-ILE-THR-GIN-HSE, O D) GLI-LIS-LIS-ASN-ASP-TRP-LIS-HIS-ASN-ILE-THR-GIN-HSENH SUB 2. CADA UNO DE LOS ANALOGOS DEL GIP SE EMPLEA COMO INGREDIENTE EFECTIVO PARA MEDICINAS EN LA CURACION DE LA DIABETES.
ES91116704T 1990-10-05 1991-09-30 Analogos de pig y su uso. Expired - Lifetime ES2076437T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2266438A JPH04145099A (ja) 1990-10-05 1990-10-05 Gip様活性を有するポリペプチド誘導体及びその用途

Publications (1)

Publication Number Publication Date
ES2076437T3 true ES2076437T3 (es) 1995-11-01

Family

ID=17430941

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91116704T Expired - Lifetime ES2076437T3 (es) 1990-10-05 1991-09-30 Analogos de pig y su uso.

Country Status (6)

Country Link
EP (1) EP0479210B1 (es)
JP (1) JPH04145099A (es)
AT (1) ATE123296T1 (es)
DE (1) DE69110101T2 (es)
DK (1) DK0479210T3 (es)
ES (1) ES2076437T3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031087A (en) * 1992-12-16 2000-02-29 The University Of Melbourne Proteinase inhibitor, precursor thereof and genetic sequences encoding same
DE69926007T2 (de) 1998-10-07 2005-12-29 Medical College Of Georgia Research Institute, Inc. Glukose-abhängiges, insulinotropisches peptid für die verwendung als osteotropes hormon
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
KR20020097236A (ko) * 2000-04-27 2002-12-31 바이오네브라스카, 인코포레이티드 타입-2 당뇨병, 내당능 장애, 또는 공복 혈당 장애에 대한감수성을 검출하기 위한 위억제성 폴리펩티드 진단 시험
WO2003103697A2 (en) * 2002-06-11 2003-12-18 Cell Therapeutics Scandinavia Ab Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
NZ554386A (en) 2004-10-25 2009-12-24 Cytos Biotechnology Ag Gastric inhibtory polypeptide (GIP) antigen arrays with VLPs and uses thereof
CA2597649A1 (en) 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Inc. Gip analog and hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
CA2913805A1 (en) 2005-11-07 2007-05-18 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
CN101578102B (zh) 2007-01-05 2013-07-17 印第安纳大学研究及科技有限公司 在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
NZ578948A (en) 2007-02-15 2012-03-30 Univ Indiana Res & Tech Corp Glucagon/glp-1 receptor co-agonists
WO2009058734A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Compounds exhibiting glucagon antagonist and glp-1 agonist activity
CA2707861A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Glucagon antagonists
CA2728284C (en) 2008-06-17 2019-09-10 Richard D. Dimarchi Glucagon/glp-1 receptor co-agonists
ES2558842T3 (es) 2008-06-17 2016-02-09 Indiana University Research And Technology Corporation Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad
TWI541023B (zh) 2008-06-17 2016-07-11 印第安納大學科技研究公司 在生理ph緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
ES2574835T3 (es) * 2008-08-07 2016-06-22 Ipsen Pharma S.A.S. Análogos del polipéptido insulinotrópico dependiente de glucosa
CA2732949C (en) 2008-08-07 2016-12-20 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
EP2376097A4 (en) 2008-12-19 2012-10-03 Univ Indiana Res & Tech Corp PEPTIDE PRODRUGS OF AMIDE-BASED GLUCAGON SUPERFAMILY
WO2010148089A1 (en) 2009-06-16 2010-12-23 Indiana University Research And Technology Corporation Gip receptor-active glucagon compounds
WO2011075393A2 (en) 2009-12-18 2011-06-23 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
KR20120123443A (ko) 2010-01-27 2012-11-08 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 대사 장애 및 비만 치료용 글루카곤 길항제-gip 항진제 콘쥬게이트
ES2661228T3 (es) 2010-05-13 2018-03-28 Indiana University Research And Technology Corporation Péptidos de la superfamilia de glucagón que muestran actividad de receptor nuclear de hormona
RU2012153753A (ru) 2010-05-13 2014-06-20 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Пептиды глюкагонового суперсемейства, обладающие активностью в отношении сопряженных с g-белком рецепторов
US8778872B2 (en) 2010-06-24 2014-07-15 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
NZ612297A (en) 2010-12-22 2015-10-30 Univ Indiana Res & Tech Corp Glucagon analogs exhibiting gip receptor activity
KR102002783B1 (ko) * 2011-06-10 2019-07-24 베이징 한미 파마슈티컬 컴퍼니 리미티드 포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용
CN103857408B (zh) 2011-06-22 2017-04-12 印第安那大学科技研究公司 胰高血糖素/glp‑1受体协同激动剂
JP6184404B2 (ja) 2011-06-22 2017-08-23 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション グルカゴン/glp−1レセプターコアゴニスト
BR112014007124A2 (pt) 2011-11-17 2017-06-13 Univ Indiana Res & Tech Corp superfamília de peptídeos gluxagon que exibem atividade no receptor glicocorticóide
ES2602486T3 (es) 2012-06-21 2017-02-21 Indiana University Research And Technology Corporation Análogos de glucagón que muestran actividad de receptor de GIP
FR2994848B1 (fr) 2012-08-30 2014-08-22 Univ Paris Curie Traitement de l'arthrose par les hormones incretines ou leurs analogues
JOP20190211A1 (ar) 2017-03-31 2019-09-15 Takeda Pharmaceuticals Co ببتيد منشط لمستقبل gip
WO2024209050A1 (en) 2023-04-05 2024-10-10 Antag Therapeutics Aps Gip activity modulators and orthostatic intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153092A (ja) * 1986-11-27 1989-06-15 Sanwa Kagaku Kenkyusho Co Ltd ヒトガストリツクインヒビトリポリペプチド(GIP)前駆体のcDNAクロ−ン

Also Published As

Publication number Publication date
JPH04145099A (ja) 1992-05-19
EP0479210A3 (en) 1992-09-02
EP0479210B1 (en) 1995-05-31
DK0479210T3 (da) 1995-07-31
ATE123296T1 (de) 1995-06-15
EP0479210A2 (en) 1992-04-08
DE69110101D1 (de) 1995-07-06
DE69110101T2 (de) 1996-02-29

Similar Documents

Publication Publication Date Title
EP0479210A3 (en) Gip analogues and use thereof
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
DE68922405D1 (de) Deletionsanaloga von magaininpeptiden.
BR1100853A (pt) Composto, composição farmacêutica, e composição veterinária
ATE139697T1 (de) Macrozyklische laktam-prokinetika
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
IL125926A0 (en) Compounds related to the amidinium family pharmaceutical compositions containing them and uses thereof
EP0317645A4 (en) 4H-3,1-BENZOXAZINE-4-ON COMPOUNDS AND SERINE PROTEASE INHIBITING MEDICINAL PRODUCTS.
ATE186302T1 (de) Etoposidanaloge
MY111439A (en) Thymosin alpha 1 derivatives
FI912336A0 (fi) Omaettade polyesterhartser.
ES2112921T3 (es) Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
AU7993587A (en) The synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
DE69127718D1 (de) Galactosamin-substituierte poly-omega-substituierte L-Glutaminsäure und/oder -Asparaginsäure
JPS6416792A (en) Guanidine related compound containing tetraphenylborate ion, its production and use thereof in peptide synthesis
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
FI830768A0 (fi) N-/n'-(2-kloretyl)-n'-nitroso-karbamoyl/-oligopeptidester och -amid och foerfarande foer dess framstaellning
ES2141795T3 (es) Procedimiento de preparacion de ureinas derivadas de alfa,omega-diaminoacidos.
JPS6419063A (en) Novel heterocyclic compound and use thereof
DE69526462D1 (de) Verfahren zur Herstellung von Peptiden aus N-Carboxyanhydridaminosäuren
EP0341658A3 (en) Desensitizer composition
ES2083961T3 (es) Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos.
ATE144257T1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479210

Country of ref document: ES